Stocks & Equities

Subway Franchisees Reportedly Hate New CEO’s Promotional Stance

Fast-food sandwich chain Subway is set to introduce new deals in January that place additional pressure on already struggling franchisees, according to The New York Post.

Subway’s Promotional CEO

Subway’s advertising agency discussed several discounts the restaurant is set to introduce in a series of private and regional conference calls, The Post’s sources said.

Some of the upcoming promotions include slashing the price of a 6-inch oven-roasted chicken sandwich from $4.25 to $2.99. In total, six sandwiches could be discounted under the leadership of John Chidsey, who was named CEO on Nov. 18.

Chidsey brings fast food experience to the table and previously served as the CEO of Burger King….CLICK for complete article

Aurora Cannabis Stock Falls to Key Support Levels

Aurora Cannabis Inc. (ACB.XTSE) shares moved more than 3% lower during Monday’s session after Cronos Group Inc. (CRON) sold its stake in Whistler Medical Marijuana Aurora for C$175 million in stock. While management expects that the strategic acquisition will add significant value, investors are concerned about potential dilution from the all-stock deal.

Melius Research analyst Rob Wertheimer started coverage on Aurora Cannabis stock with an Overweight rating and a price target of C$17 per share, calling it his top pick in the cannabis space. While the analyst firm anticipates overcapacity issues in the future, Wertheimer notes that Aurora has taken measures to capture market share while lowering production costs to preserve margins…CLICK for complete article

Are Cannabis Stocks Finally a Steal of a Deal?

Growth investing can be extremely challenging, especially when the stocks in which you are investing have no earnings. Speculative cannabis investors have been taught a harsh lesson over the course of the past year, with many of these stocks being absolutely crushed in the latter half of 2019. How bad has it been? Well, let’s look at some of the performances of some of the better-known stocks over the past year.

Cannabis stocks have been crushed

The better-known stocks in the Canadian cannabis space are AphriaAurora Cannabis, and Canopy Growth. It is interesting to note that there is not one single stock among the bunch that has survived the carnage. Not a single stock has the investor clout and financial strength.

Every single stock has basically been cut in half or more over the past year. Aphria has fallen almost 48% from a year ago. Aurora has fallen even more, down 55% year over year. Even Canopy Growth, which was arguably the biggest and best of the bunch, is down 45% at the time of this writing.

Even owning a basket of stocks wouldn’t have helped much over this time frame. Horizons Marijuana Life Sciences ETF has been similarly crushed, down almost 48% over the same period. You have to realize how big an issue this is, since an ETF is usually a good way to mitigate a loss by diversifying….CLICK for complete article

Why Aurora Cannabis, Canopy Growth, and HEXO Shares Are Jumping Today

Shares of Canopy Growth (NYSE:CGC) were jumping 15% higher as of 11:51 a.m. EST on Wednesday, with two of its peers also enjoying nice gains. Aurora Cannabis (NYSE:ACB) shares were also up 15%, while shares of HEXO (NYSE:HEXO) rose 8.8% after vaulting as much as 14.8% higher earlier in the day.

There were several reasons for the upward moves for these Canadian marijuana stocks. Bank of America analyst Christopher Carey upgraded Canopy Growth stock to a buy rating from a neutral rating. This upgrade appears to have had a halo effect to some extent on Canopy’s peers, especially Aurora and HEXO. In addition, Aurora announced on Tuesday that 94% of the holders of its convertible debentures that mature in March 2020 have elected to accept the company’s offer to convert the debt into stock.

It’s great that Aurora won’t have to scramble to raise 230 million Canadian dollars to pay off its debt within the next few months. It’s also encouraging that a top analyst is now more positive about Canopy Growth. But the underlying reason behind these three stocks’ jumps today is that some investors now think that the sell-off from the last several months that’s affected nearly every Canadian marijuana stock finally went too far….CLICK for complete article

The Cannabis Culling Has Wall Street Disappointed

It’s now just over a year since Canada legalized recreational use of marijuana, and Wall Street is thoroughly disappointed.

What was supposed to have been a massive killing in one of the hottest new markets has been worse than lackluster.

A much clearer, if not dire picture emerges with the culling of cannabis stocks following Q3 earnings releases.

The disastrous results show a lineup of companies who haven’t been able to come up with a good strategy for growing, packaging and distributing. They haven’t been able to make legal weed more attractive than illegal weed. Perhaps it was a bit presumptuous to simply think that making it legal would bring all weed smokers to their doorsteps….CLICK for complete article